戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              CNV was present in 148 patients (49%) and retinal atroph
2                                              CNVs comprise a large proportion of variation in human g
3                                              CNVs have large mirror effects on FC at the global and r
4                                              CNVs hitting loss-of-function intolerant genes were asso
5                                              CNVs were generated from exome sequencing of 4913 schizo
6 presence of treatment-naive quiescent type 1 CNV and by a factor of 0.46 (95% CI, 0.41-0.51) in the p
7 with a potential protective effect of type 1 CNV on the RPE and overlying neurosensory retina.
8 calizing with quiescent and exudative type 1 CNV.
9 41-0.51) in the presence of exudative type 1 CNV.
10 ing magnetic resonance imaging data from 101 CNV carriers, 755 individuals with idiopathic ASD, SZ, o
11                 As a result, a total of 1649 CNV regions (CNVRs) were successfully identified after m
12 uding the well-established pathway of type 2 CNV progression to FGL and the progression of type 1 fib
13 verse phenotypes in individuals with 16p11.2 CNVs, and synthesize preclinical findings from transgeni
14 ings from transgenic mouse models of 16p11.2 CNVs.
15 elopmental disorders associated with 16p11.2 CNVs.
16                                      22q11.2 CNVs differentially modulate intellectual functioning an
17            We profiled the impact of 22q11.2 CNVs on neurobehavioral measures relevant to ASD and psy
18  overlap with regulatory regions, with 23/28 CNVs disrupting histone peaks in ENCODE (p < 0.009).
19 A events from TCGA and COSMIC; (iii) 112 674 CNV-ceRNA events from TCGA; (iv) 67 066 SNP-ceRNA events
20                  In 40% of cases (41/102), a CNV was detected on FA.
21 pact of gene dosage variation triggered by a CNV spanning the SEC10 gene on SEC10 expression at both
22  and indicates new areas of discussion about CNV in this disease.
23 ction of leukocytes within the choroid after CNV induction.
24  their flexibility in modeling the aggregate CNV effects, their ability to capture effects from diffe
25 els to estimate the effect size on IQ of all CNVs, including undocumented ones.
26  set of voltage-gated calcium channels among CNVs called from both exome sequencing and genotyping ar
27 DDs from combined radiology, morphology, and CNV assessments may be possible.
28 ox proportional hazards models using SPM and CNV data for 29 different TCGA cohorts.
29 ns between the extent of angioid streaks and CNV or macular atrophy were investigated using regressio
30            Furthermore, we integrated SV and CNV data into a unifying karyotype-graph structure to pr
31  55 different pathogenic point mutations and CNVs in 13 genes/loci responsible for nonsyndromic and s
32 findings, facial morphological variants, and CNVs, statistically significant relationships were found
33 eneity without the need to define artificial CNV loci as required in current kernel methods.
34               We evaluated if ASCAT-assessed CNV are associated with survival outcomes in 56 patients
35 1.5-3% of patients carry epilepsy-associated CNVs.
36 ce that carriers of schizophrenia-associated CNVs had poorer block design performance (P = 0.0307).
37 arriers of specific schizophrenia-associated CNVs showed poorer performance than non-carriers in imme
38 prevalence and penetrance of large autosomal CNVs and chromosomal aneuploidies using a standard CNV d
39 hich confirmed the results of SNP chip-based CNV analysis.
40 zumab every 4 weeks with documented baseline CNV type, total area, and leakage area were analyzed.
41                     With increasing baseline CNV total area and leakage area, the incidence rate of f
42 additional evidence for the role of baseline CNV features (CNV type, total area, and leakage area) in
43       We do not find any association between CNV burden and cognition.
44 s using ASD subdomains distinguished between CNV cases with 76% accuracy.
45     Cognitive deficits were observed in both CNV groups, with the lowest IQs in deletion carriers.
46  association areas, which was absent in both CNV groups.
47                                         Both CNVs are associated with autism spectrum disorder (ASD),
48  and transposable elements (TEs) affected by CNVs, we revealed that the variation statuses of genes a
49               Compared to other CNV callers, CNV Radar showed high sensitivity and specificity.
50 l fluid than eyes with predominantly classic CNV (both P < 0.01).
51              Eyes with predominantly classic CNV (mean best-corrected visual acuity [BCVA], 48.2 lett
52                         The catalog of CNVs, CNV-overlapping genes, and their genotypes in a top mode
53 d RPE atrophy without evidence of coexisting CNV (n=81).
54 Similar results were observed when comparing CNV Radar calls to single nucleotide polymorphism array
55 ed for development of macular complications (CNV, large areas of RPE atrophy [at least 250 mum in dia
56 e rate with FISH for del17p, a risk defining CNV event (88% in POLLUX and 90% in CASTOR), therefore a
57 uggest that CONCUR is well powered to detect CNV effects in the Swedish Schizophrenia Study and the T
58 n OCT alone can be relied upon for detecting CNV activity while monitoring eyes with neovascular AMD.
59 ivity and specificity of SD OCT in detecting CNV activity was 91% (95% confidence interval [CI], 84%-
60 greement between SD OCT and FFA in detecting CNV activity.
61  sensitivity of the examination in detecting CNV in chronic CSCR.
62 ir ability to capture effects from different CNV features, and their accommodation of effect heteroge
63                  Nine eyes (12.7%) displayed CNV, 9 eyes (12.7%) had large areas of RPE atrophy, and
64                           The 16p11.2 distal CNV predisposes carriers to e.g., autism spectrum disord
65 btle differences in ASD profiles distinguish CNV groups.
66 ree from a definition of locus and evaluates CNV-phenotype associations by comparing individuals' cop
67 molecule inhibitor of RUNX1, in experimental CNV is reported.
68 =7), RPE atrophy with a history of exudative CNV (n=10), and RPE atrophy without evidence of coexisti
69 xima A), 3.55 (0.16) mm(2) in the fellow eye CNV cohort (Proxima B), and 2.96 (0.25) mm(2) in the fel
70 29) and -7.57 (1.26) in Proxima B fellow eye CNV cohort, and -11.48 (3.39) and -8.37 (3.02) in Proxim
71 ve (cAUC) kernel" to model the multi-feature CNV effects.
72 dence for the role of baseline CNV features (CNV type, total area, and leakage area) in influencing v
73  and the progression of type 1 fibrovascular CNV to FGL or fibroatrophic lesion.
74  a FGFR1-ERLIN2 fusion associated with focal CNVs in both genes in a single ASCP.
75 expected role of non-NLRP3 inflammasomes for CNV and suggest that combination therapies targeting inf
76 ate that the utility of exome sequencing for CNV calling has yet to be maximized, and note that singl
77 ression signal and allelic shift signals for CNV calling.
78 f-heterozygosity (LOH) which is valuable for CNV identification.
79 r facial morphological variants, and 183 for CNVs.
80                                    HER2 gene CNV was also assessed in formalin-fixed paraffin-embedde
81 ExomeDepth) to expand our set of single-gene CNVs and leveraged two different approaches for validati
82 t to be maximized, and note that single-gene CNVs should be included in gene-focused studies using ot
83 to the potential contribution of single-gene CNVs to schizophrenia, indicate that the utility of exom
84                                  In general, CNV data predicts prognosis better than SPM data with th
85                                      Genomic CNV may be a novel prognostic biomarker for WHO grade IV
86 st patient, sequenced using the 10X Genomics CNV solution with sequencing coverage ~0.03x, SBMClone r
87                                         HER2 CNV examination could distinguish healthy individuals an
88 tion for survival differences based on HIF1A CNV and mRNA expression.
89                            Remarkably, HIF1A CNV had a markedly stronger correlation with L2HGDH expr
90 neralized epilepsy patients have the highest CNV burden in all categories tested, followed by develop
91                                     However, CNV loci are arbitrarily defined and different locus def
92                           Distribution of HP CNV genotype was: HP1-1 n=132 (18.1%); HP2-1 n=342 (46.8
93    We found no evidence of association of HP CNV or rs200999 with functional outcome, ICH volume or P
94                  We hypothesised that the HP CNV associates with long-term outcome beyond the first y
95           To investigate mediation of the HP CNV effect by haptoglobin expression level, as opposed t
96                                       The HP CNV was typed using quantitative PCR in 1299 aSAH surviv
97  44 patients with aSAH and related to the HP CNV.
98 haptoglobin expression independent of the HP CNV.
99 tients into three groups according to the HP CNV: 1-1, 2-1 or 2-2 and also dichotomised HP into HP1-c
100 ing-based transcriptional signature of human CNV, characterizes its compositional pattern of immune a
101 e rare variant association studies, identify CNVs associated with major disease categories, and illus
102                                           If CNV was detected by OCT angiography (OCTA), its location
103  the en-face and the cross-sectional images, CNV was identified in 13 eyes with the rest OCT-A and in
104                            More importantly, CNV Radar demonstrated its utility in the clinical trial
105  CNV, (2) whether inflammasome activation in CNV occurs via NLRP3 or also through NLRP3-independent m
106 ctivation induces inflammasome activation in CNV.
107 brain-behavior relationships were altered in CNV carriers, we further tested for interactions between
108 However, we observed striking differences in CNV burden across epilepsy types and investigated CNV ca
109 cal epilepsy patients, showed an increase in CNV burden in at least one tested category compared to c
110  (DEGs) that were significantly increased in CNV compared with control tissue.
111 ration of a stringent filtering procedure in CNV studies with suitable bioinformatics approaches can
112                         However, its role in CNV remains to be elucidated.
113 n processing speed and cortical thickness in CNV carriers, implicate aberrant development of the cort
114 des functionality for summarizing individual CNV calls across a population, assessing overlap with fu
115 nt inflammasome activation mechanisms induce CNV.
116  163 (CD163)(+) macrophages in laser-induced CNV lesions and higher expression of CD163(+) monocytes
117 ibitor PLX5622 on experimental laser-induced CNV.
118                                 Inflammatory CNV may be rarely associated with pregnancy.
119       She was diagnosed with an inflammatory CNV based on the following multimodal imaging findings:
120     Herein, we report a case of inflammatory CNV during pregnancy and describe a previously unreporte
121 nt may offer synergistic benefits to inhibit CNV.
122          These models will help to interpret CNVs identified in the clinic.
123 urden across epilepsy types and investigated CNV categories.
124                 Here, we present the largest CNV investigation in epilepsy to date with 10 712 Europe
125                 Results may explain why many CNVs affect a similar range of neuropsychiatric symptoms
126 k and which epilepsy subtypes carry the most CNV burden, have not been explored on a genome-wide scal
127 tive and safe drug in cases of active myopic CNV; however, a larger number of patients and a longer f
128 between inflammatory, idiopathic, and myopic CNV may be challenging.
129 h the absence of tomographic signs of myopic CNV, and the presence on autofluorescence of multiple hy
130                         Patients with myopic CNV younger than 40 years needed fewer injections (2.00
131 n of ziv-aflibercept in patients with myopic CNV.
132 itical role in choroidal neovascularization (CNV) and may, therefore, be potential targets to modulat
133 he type of the choroidal neovascularization (CNV) at the start of treatment were similar between the
134                Choroidal neovascularization (CNV) can complicate AMD and lead to severe visual acuity
135 d in promoting choroidal neovascularization (CNV) in age-related macular degeneration (AMD), but cent
136 nal profile of choroidal neovascularization (CNV) in body donor eyes with neovascular age-related mac
137 ral GA without choroidal neovascularization (CNV) in either eye (N = 295).
138                Choroidal neovascularization (CNV) in pregnancy has rarely been described.
139         Myopic choroidal neovascularization (CNV) is the most common sight-threatening complication a
140 mmune cells in choroidal neovascularization (CNV), a hallmark of the human wet, or neovascular age-re
141 de novo and known recurrent neuropsychiatric CNVs.
142 eral cognitive ability than nonschizophrenia CNV carriers in discovery (beta = -0.66, 95% confidence
143    CoDE-seq also identified 28 rare or novel CNVs associated with intellectual disability in 22 addit
144 rapid acquisition of novel, high copy number CNVs during adaptation to azole antifungal drugs.
145  of cases identified by FFA only were occult CNV lesions.
146  of 15 letters or more than eyes with occult CNV (mean BCVA, 57.9 letters at baseline; P < 0.01).
147                             Eyes with occult CNV at baseline showed higher incidence rates of first s
148 nificantly change in the peripheral blood of CNV mice.
149 ntation artifacts and incomplete coverage of CNV on SS-OCTA en face images may impede identification
150 th early/intermediate AMD and a diagnosis of CNV in the fellow eye progressed to CNV fastest (at a ra
151 is of the literature exploring the effect of CNV burden on general intelligence.
152  The proposed method captures the effects of CNV dosage and length, accounts for the numerical nature
153                                Evaluation of CNV Radar in a public multiple myeloma dataset demonstra
154 uid, and/or cystoid spaces); (2) evidence of CNV activity on FFA identified by the presence of leakag
155 D OCT data were analyzed for (1) evidence of CNV activity on SD OCT (presence of subretinal fluid, in
156 rrelated with cortical spatial expression of CNV genes in neurotypical adults.
157  en face images may impede identification of CNV.
158 lication of MLPA aids the identifications of CNV and aneuploidy in childhood B-ALL.
159  clinical implications for the management of CNV and lead to new therapeutic strategies to prevent at
160 l types involved in a laser-induced model of CNV in mice.
161 ated OCTA en face images for the presence of CNV masked to all other images of the patient.
162  streaks was associated with the presence of CNV when adjusted for age and sex (odds ratio, 1.9; 95%
163 aks are associated with an increased risk of CNV and macular atrophy, even after adjustment for age.
164 ing was systematically assessed for signs of CNV and macular atrophy.
165 ence of leakage, and (3) cross-tabulation of CNV activity identified by FFA and SD OCT by office visi
166                                  Analysis of CNVs containing inverted duplicated DNA sequences using
167                               The catalog of CNVs, CNV-overlapping genes, and their genotypes in a to
168  that lead to the formation of this class of CNVs.
169 ly annotating the regulatory consequences of CNVs.
170  the reads and utilizes it for correction of CNVs calls.
171  use it to annotate regulatory disruption of CNVs from 14,891 independent genome-sequenced individual
172 ntolerant" (pLI) best explains the effect of CNVs on IQ and autism risk.
173 family study, we investigated the effects of CNVs on specific cognitive abilities.
174 ements act as hot spots for the formation of CNVs.
175 es, and illustrate the pleiotropic impact of CNVs in human disease.
176 ical analyses revealed that the incidence of CNVs increases significantly in SD-rich regions, indicat
177 omic resource for unveiling the incidence of CNVs that affect gene content and for identifying sequen
178 tal detection and computational inference of CNVs from SNP array and next-generation sequencing data
179     This paper investigates the influence of CNVs on cognition.
180  significantly associated with the number of CNVs (OR 1.20, 95% CI 1.00-1.44, p = 0.05, adjusted OR f
181 etic cause, with 13% of these as a result of CNVs, demonstrating a remarkably higher prevalence of mo
182                    To understand the role of CNVs across human diseases, we examine the CNV genomic l
183                           An expanded set of CNVs generated from integrating multiple approaches show
184 elivers a comprehensive genome-wide study of CNVs affecting barley gene content and implicates SDs in
185  to identify all disease-associated types of CNVs.
186 at CNV Radar was able to detect a variety of CNVs associated with risk of progression, and we observe
187 EGs, as confirmed by immunohistochemistry on CNV tissue and protein analysis of vitreous samples.
188  The model applied in this study, trained on CNVs encompassing >4,500 genes, suggests highly polygeni
189                          Conversion to GA or CNV in the fellow eye occurred in 30% and 6.7% of partic
190                         Progression to GA or CNV was observed frequently in eyes with early/intermedi
191 ermediate AMD, rates of progression to GA or CNV were 2.0 and 3.2 per 100 person-years, respectively.
192 led 3 progression pathways from the original CNV: 1) progression to type A, followed by RPE erosion a
193  that CNV Radar is more sensitive than other CNV detection methods, accurately detects clinically imp
194                            Compared to other CNV callers, CNV Radar showed high sensitivity and speci
195                                     Overall, CNV Radar exhibited high concordance with standard metho
196 to any SHRM or PED to ensure that a possible CNV was captured in its entirety.
197                              Here we present CNV Radar, a software tool that utilizes next-generation
198 nd that complement and inflammasomes promote CNV through independent mechanisms.
199 um (RPE) or rather in non-RPE cells promotes CNV, (2) whether inflammasome activation in CNV occurs v
200  non-RPE cells but not in RPE cells promotes CNV.
201                                   Quantified CNV was reported as log R and BAF segment counts. Result
202                  Input into ASCAT quantified CNV using the segmentation function to measure copy numb
203 (RPE) atrophy with treatment-naive quiescent CNV (n=7), RPE atrophy with a history of exudative CNV (
204                               To detect rare CNV associations, kernel-based methods have been shown t
205 levels of autism risk conferred by most rare CNVs remain unknown.
206  model to predict expression effects of rare CNVs and use it to annotate regulatory disruption of CNV
207 al profiles associated with these reciprocal CNVs in conjunction with brain imaging measures have not
208                                    Recurrent CNVs reveal genes under positive selection, sites of gen
209 d 2,241 eligible genes in the 1,532 reported CNVs, of which they classified 432 as high-priority ADHD
210 q13.3 deletion represents the strongest risk CNV for genetic generalized epilepsy across the whole ge
211   Our findings show that the known high-risk CNVs are not only associated with schizophrenia and othe
212                  The characteristics of risk CNVs vary tremendously across and within epilepsy types.
213 ntegrative analysis of focal and large-scale CNV events in multiscale resolution using either bulk or
214 ting that previously reported megabase-scale CNVs in neurons arise at later stages of development.
215                                Schizophrenia CNV carriers had lower general cognitive ability than no
216 ociation between cognition and schizophrenia CNV status, covarying for age and sex.
217   We examined the effect of 12 schizophrenia CNVs on cognition in those with schizophrenia.
218  variants (CNVs) as well as certain specific CNVs increase the risk of developing schizophrenia.
219 nd chromosomal aneuploidies using a standard CNV detection algorithm not designed for detecting mosai
220                              After stringent CNV calling procedures, and standardized FreeSurfer imag
221  for which SPM data was more predictive than CNV data and the predictive accuracy is good for all mod
222                         We demonstrated that CNV Radar is more sensitive than other CNV detection met
223 c multiple myeloma dataset demonstrated that CNV Radar was able to detect a variety of CNVs associate
224                        Our results show that CNV carriers have reduced volume in some of the subcorti
225                                          The CNV area of choroidal flatmounts was evaluated by immuno
226 suggest a role for alpha attenuation and the CNV in specific visual content anticipation beyond gener
227 tes of attenuated alpha oscillations and the CNV.
228 rder to specific cell classes as well as the CNV-region genes they express.
229 tion of Ro5-3335 significantly decreased the CNV area 7 days after laser injury, and when combined wi
230 "copy number profile curves" to describe the CNV profile of an individual, and the "common area under
231 f CNVs across human diseases, we examine the CNV genomic landscape of 100,028 unrelated individuals o
232 , T cells, and natural killer T cells in the CNV.
233 ngal drug can lead to a dramatic loss of the CNV and reversion to the progenitor genotype and drug su
234 2 had a significantly faster decrease of the CNV lesion size, as revealed by in vivo imaging and immu
235 f RPE atrophy in topographic relation to the CNV lesion was then analyzed using mixed-effects logisti
236 usted proportion of clinical visits when the CNV was graded active over 3 years was similar between r
237                                          The CNVs fully overlap with 18.3% of protein-coding genes, w
238                We then successfully used the CNVs as markers to analyze population structure and migr
239 cell karyotype analysis indicates that these CNVs appear to arise via a dicentric chromosome intermed
240 nosis of CNV in the fellow eye progressed to CNV fastest (at a rate of 15.2 per 100 person-years), an
241 rates per 100 person-years of progression to CNV (3.2-11.9) or GA (2.0-7.8) in the other subgroups.
242 al fluid as evaluated by OCT with respect to CNV type, total CNV, and leakage area.
243 he degree of evidence of flow signals due to CNVs.
244 uated by OCT with respect to CNV type, total CNV, and leakage area.
245                            We integrated two CNV calling methods (XHMM and ExomeDepth) to expand our
246                                   We uncover CNV associations with four major disease categories, inc
247                    This study therefore used CNV and control specimens that were formalin-fixed and p
248 le-exome sequencing and copy-number variant (CNV) analysis of the tumors.
249 mples with whole-genome copy-number variant (CNV), whole-exome sequencing, and Assay for Transposase-
250 large and rare copy number genetic variants (CNVs) as well as certain specific CNVs increase the risk
251              Some rare copy number variants (CNVs) are associated with schizophrenia risk and affect
252            Deleterious copy number variants (CNVs) are identified in up to 20% of individuals with au
253                        Copy number variants (CNVs) are pervasive in several animal and plant genomes
254                  Large copy-number variants (CNVs) are strongly associated with both developmental de
255                        Copy number variants (CNVs) are suggested to have a widespread impact on the h
256                        Copy number variants (CNVs) are the gain or loss of DNA segments in the genome
257    16p11.2 and 22q11.2 Copy Number Variants (CNVs) confer high risk for Autism Spectrum Disorder (ASD
258 ich characteristics of copy number variants (CNVs) confer most epilepsy risk and which epilepsy subty
259 ers of large recurrent copy number variants (CNVs) have a higher risk of developing neurodevelopmenta
260               Specific copy number variants (CNVs) have been robustly associated with intellectual di
261 loci including several copy number variants (CNVs) of large effect and hundreds of loci of small effe
262   Functional impact of copy number variants (CNVs) stems from both the proportion of genic and regula
263 -scale allele-specific copy number variants (CNVs) using an ensemble of methods.
264  No large scale mosaic copy number variants (CNVs) were detectable in normal fetal human brains, sugg
265  gradually accumulates copy number variants (CNVs), and its telomere lengths are short but constant.
266  common to overlapping copy number variants (CNVs), as well as on protein-protein interactions and in
267 nt information such as copy number variants (CNVs).
268 l variants and genetic copy number variants (CNVs).
269 ygous SNVs, or de novo copy number variants (CNVs); however, most ASD cases continue to lack a geneti
270 tions and the contingent negative variation (CNV).
271 arrangements and gene copy number variation (CNV) are two important tools for genome evolution and so
272                  Gene copy number variation (CNV) could be detected in these patients in liquid biops
273 nt mutation (SPM) and copy number variation (CNV) data, gene-level and pathway-level models for a div
274     Cancer associated copy number variation (CNV) events provide important information for identifyin
275             A HP gene copy number variation (CNV) generates HP1 and HP2 alleles, while the single-nuc
276                       Copy number variation (CNV) has been examined in many species and is recognized
277                       Copy number variation (CNV) is a major type of structural genomic variation tha
278 rpretation of genomic copy number variation (CNV) remains a challenge and has important consequences
279  haptoglobin) exhibit copy number variation (CNV), giving rise to HP1 and HP2 alleles, which influenc
280 ors (ASCAT) assesses copy number variations (CNV) while accounting for aberrant cell fraction and tum
281                 Some copy number variations (CNV), associated with novel subtypes of childhood B-ALL,
282 ccurate in detecting copy number variations (CNV).
283 rs caused by genomic copy number variations (CNVs) and gene expression data from healthy subjects.
284 ction of whole-exome copy number variations (CNVs) and point mutations in coding regions.
285                      Copy number variations (CNVs) greatly contribute to intraspecies genetic polymor
286 omatic mutations and copy number variations (CNVs) not evident in transcriptomics data.
287                      Copy number variations (CNVs) of the human 16p11.2 genetic locus are associated
288 and duplications are copy number variations (CNVs) that predispose to developmental neuropsychiatric
289 one of the predicted copy number variations (CNVs) were identified, which confirmed the results of SN
290 s) to large, complex copy number variations (CNVs), have been reported in patients with ID and other
291 rs prevalent genomic copy number variations (CNVs), leading to mis-expression of ~68% of SRGs during
292  deletions (indels), copy-number variations (CNVs), loss of heterozygosity (LOH) and complex rearrang
293 which are pathogenic copy number variations (CNVs), play an important role in the initiation and prog
294 viduals with 16p11.2 copy number variations (CNVs).
295        The exploratory outcome measures were CNV size, IOP and the number of injections needed in eac
296                                         When CNV effects on IQ are accounted for, autism susceptibili
297               In addition, we tested whether CNVs hitting genes in schizophrenia-enriched gene sets (
298                                  Genome-wide CNV breakpoint association showed not only significant l
299 resistance to MD, we performed a genome-wide CNV detection using next generation sequencing on the in
300 dentifying sequence features associated with CNV formation.

 
Page Top